erlotinib hydrochloride has been researched along with hts 466284 in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (hts 466284) | Trials (hts 466284) | Recent Studies (post-2010) (hts 466284) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 43 | 0 | 27 |
Protein | Taxonomy | erlotinib hydrochloride (IC50) | hts 466284 (IC50) |
---|---|---|---|
Chain A, TGF-beta receptor type I | Homo sapiens (human) | 0.051 | |
Chain A, TGF-beta receptor type I | Homo sapiens (human) | 0.051 | |
TGF-beta receptor type-1 | Homo sapiens (human) | 0.0522 | |
TGF-beta receptor type-2 | Homo sapiens (human) | 0.4 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.74 | |
Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | 1.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dolman, ME; Fretz, MM; Goldschmeding, R; Hennink, WE; Kok, RJ; Lacombe, M; Nguyen, TQ; Pato, J; Prakash, J; Storm, G | 1 |
1 other study(ies) available for erlotinib hydrochloride and hts 466284
Article | Year |
---|---|
Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors.
Topics: Cells, Cultured; Chemistry, Pharmaceutical; Drug Carriers; Endocytosis; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Fibrosis; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; Kidney Tubules, Proximal; Kinetics; Muramidase; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyrroles; Quinazolines; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta | 2008 |